Mechanistically, we show that loss of USP21 in HCC cell lines results in a reduction of BRCA2, increased DNA damage accumulation and a concomitant tumor growth defect that partially depends on BRCA2 (Fig. 5). The gene discussed is BRCA2; the disease is hepatocellular carcinoma.